Releases Geral
Cellebrite Experts to Moderate Human Trafficking Panel, Present on Digital Intelligence at International Association of Chiefs of Police (IACP) Expo and Conference
AGÊNCIA DE COMUNICAÇÃO Conteúdo de responsabilidade da empresa 10 de outubro de 2023
Cellebrite DI Ltd
TYSONS CORNER, Va., PETAH TIKVA, Israel and SAN DIEGO, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, will both sponsor and have a large presence at the annual International Association of Chiefs of Police (IACP) expo and conference, which kicks of Saturday, October 14 at the San Diego Convention Center. With senior leaders engaging with law enforcement and presenting on best practices in digital intelligence, Cellebrite is reinforcing its commitment to advancing justice around the globe. Highlights of Cellebrites key contributions include:
Cellebrite to moderate a live panel with key philanthropic partners in the fight against human trafficking
When: Saturday, October 14 at 12:15 p.m. PST
Where: Solutions Presentation Theatre: Booth 639
Who: Jared Barnhart, Digital Intelligence Specialist at Cellebrite with moderate a panel of industry leaders and experts who are leading the fight against human trafficking. Panel members include:
- Derrick Driscoll, COO National Center for Missing and Exploited Children (NCMEC)
- Matt Parker, Co-founder of the Exodus Road
- Glen Pounder, Founding board member of Raven
Cellebrite to Present Expertise in Unraveling Crime Mysteries
When: Saturday, October 14 at 4 p.m.
Where: Solutions Presentation Theatre Booth 639
Who: Jared Barnhart, Digital Intelligence Specialist at Cellebrite, will give real-world examples of how digital intelligence solutions can greatly enhance investigations and accelerate justice.
Our team is eager to connect with the law enforcement community and talk about the best practices when it comes to digital intelligence, says Marque Teegardin, President, Cellebrite Americas. We are proud to once again sponsor and participate in this valuable conference where 16,000+ of Americas finest gather to put their heads together to collectively advance justice.
Attendees and the media are encouraged to stop by our Booth 4907 throughout the conference to connect with our team.
Media Contact:
Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910
Investor Relations Contact:
Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760
About Cellebrite
Cellebrites (NASDAQ: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrites Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com.
A OESP nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP e sao de inteira responsabilidade da GlobeNewswire
Leia também
-
Releases Geral Duck Creek Technologies Reconhece IAT Insurance Group e Coforge com seu prêmio Standard of Excellence Award
29 de maio de 2024BOSTON, May 29, 2024 (GLOBE NEWSWIRE) -- Hoje, a Duck Creek Technologies, fornecedora de soluções inteligentes que definem o futuro do seguro de propriedade e acidentes (
Saiba Mais -
Releases Geral Junshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC Patients
2 de janeiro de 2024Junshi Biosciences SHANGHAI, China, Jan. 02, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven
Saiba Mais -
Releases Geral Nyxoah Announces Partnership with ResMed in Germany
2 de outubro de 2023Nyxoah Nyxoah Announces Partnership with ResMed in GermanyCreates a continuum of care in the German obstructive sleep apnea market Mont-Saint-Guibert, Belgium September 28, 2023, 10:30pm CET / 4:30pm
Saiba Mais